Gut microbes and their metabolites are actively involved in the development and regulation
of host immunity, which can influence disease susceptibility. Herein, we review the most …

Inflammatory bowel diseases (IBD) are chronic, progressive and relapsing inflammatory
disorders of unknown etiology that may cause disability over time. Data from epidemiologic …

It is unclear regarding associations of dietary patterns with a wide range of chronic diseases
and which dietary score is more predictive of major chronic diseases. Using the UK Biobank …

Ischemic heart disease (IHD) and type-2 diabetes mellitus (T2DM) remain major health
problems worldwide and commonly coexist in individuals. Gut microbial metabolites, such …

Introduction Patients with epilepsy are particularly vulnerable to the negative effects of
anxiety disorders. In particular, temporal lobe epilepsy with anxiety disorders (TLEA) has …

Diet is intimately linked to the gastrointestinal (GI) tract and has potent effects on intestinal
immune homeostasis. Inflammatory bowel disease (IBD) is characterized by chronic …

Inflammatory bowel diseases (IBD) represent a global phenomenon, with a continuously
rising prevalence. The strategies concerning IBD management are progressing from clinical …

Inflammatory bowel disease (IBD), a non-specific chronic idiopathic inflammatory condition
of the digestive system, requires lifelong treatment in which drugs are the mainstay, along …

Fecal microbiota transplantation (FMT) has emerged as a promising therapeutic modality
within the domain of inflammatory bowel disease (IBD). While FMT has secured approval …

Human studies on the effect of rosiglitazone on inflammatory bowel disease (IBD) are still
lacking. We investigated whether rosiglitazone might affect IBD risk by using the …